Diagnostic Pathology in the Era of Precision Medicine
DOI:
https://doi.org/10.51985/LSHU1451Abstract
The ever-increasing importance of targeted therapy in the management of cancerous and non-neoplastic diseases calls for novel, advanced techniques of diagnostic pathology. The past decade has witnessed substantial changes in how cancer patients are managed, with a pronounced focus on precision medicine based on genomic profiles and gene expression analysis, thus discarding the “one-size-fits-all” approach1.
References
Martínez-Jiménez F, Muiños F, Sentís I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, Mularoni L, Pich O, Bonet J, Kranas H, Gonzalez-Perez A. A compendium of mutational cancer driver genes. Nature Reviews Cancer. 2020 Oct;20(10):555-72.
Dietel M: Molecular Pathology: A Requirement for Precision Medicine in Cancer. Oncol Res Treat 2016;39:804-810. doi: 10.1159/000453085
McCarthy JJ, McLeod HL and Ginsburg GS. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 2013; 5: 189sr4.
Hodson R. Precision medicine. Nature 2016; 537: S49.
Perakis S and Speicher MR. Emerging concepts in liquid biopsies. BMC Med 2017; 15: 75.
Buder A, Tomuta C and Filipits M. The potential of liquid biopsies. Curr Opin Oncol 2016; 28: 130–134
Wang J, Chang S, Li G and Sun Y. Application of liquid biopsy in precision medicine: opportunities and challenges. Front Med 2017; 11: 522–527.
Roychowdhury S, Chinnaiyan AM. Translating cancer genomes and transcriptomes for precision oncology. CA Cancer J Clin 2016;66:75–88.
Senft D, Leiserson MDM, Ruppin E, Ronai ZA. Precision oncology: the road ahead. Trends Mol Med 2017;23:874–98
Wirka RC, Pjanic M, Quertermous T. Advances in Transcriptomics Investigating Cardiovascular Disease at Unprecedented Resolution. Cardiovascular Omics Compendium. 2018;1200-1220.
Kumar S, Vo AD, Qin F, Li H. Comparative assessment of methods for the fusion transcripts detection from RNA-Seq data. Sci Rep. 2016;6:21597. doi: 10.1038/srep21597.
Gawad C, Koh W, Quake SR. Single-cell genome sequencing: current state of the science. Nat Rev Genet. 2016;17:175–188. doi: 10.1038/nrg.2015.16
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012;486:346–52
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011;121:2750–67.
McDonald 3rd ER, de Weck A, Schlabach MR, Billy E, Mavrakis KJ, Hoffman GR, et al. Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening. Cell 2017;170: 577–92.
Xie SJ, Zhang Y, Qu LH, Xu H. A helm model for microRNA regulation in cell fate decision and conversion. Sci China Life Sci 2013;56:897–906.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Summaya Shawanna, Yasmeen Taj
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
